Trial Profile
Randomized phase II study of TS-1/CPT-11 versus TS-1/TXL in advanced/recurrent gastric cancer (OGSG 0402)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Nov 2021
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary) ; Paclitaxel (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms OGSG 0402
- 10 Oct 2010 Results presented at the 35th Congress of the European Society for Medical Oncology (ESMO).
- 04 Jun 2010 Final results have been presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).
- 03 Apr 2007 New trial record.